Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs. Epinephrine During Neonatal Cardiopulmonary Resuscitation
NCT05738148Phase 1Active, not recruiting
- Sponsor
- University of Alberta
- Start
- Nov 2023
- Primary completion
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised trial of vasopressin in cardiac arrest (SCA) (2 arms), sponsored by University of Alberta. Primary endpoint: Time to Return of Spontaneous Circulation up to 60 minutes. Started Nov 2023; status: active, not recruiting.
02
Drugs
vasopressin
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT05738148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05738148.